CRYO SAVE GROUP : -Save Group N.V.: Purchase Shares Chairman
11/03/2011| 01:05am US/Eastern
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price of ?4.14 on 1 November 2011.
Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group's issued share capital.
| Cryo-Save Group|| + 31 (0) 575 548 998|
| Arnoud van Tulder, Chief Executive Officer || |
| || |
| SPJ Financiėle Communicatie (The Netherlands)|| +31 (0)20 647 8181|
| Kees Jongsma/Leon Melens|| |
| Daniel Stewart & Company plc (UK)|| + 44 (0) 20 7776 6550|
| Sean Lunn|| |
| || |
| College Hill (UK)|| + 44 (0) 20 7457 2020|
| Rozi Morris/ Adrian Duffield|| |
| || |
Free footage is available on www.videobankonline.com:
About Cryo-Save (www.cryo-save.com/group:
Cryo-Save, the leading international family stem cell bank, already stores more than 194,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Click here for PDF press release:
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE